trial · primary record
M0324
Advanced Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 77 |
| Primary completion | 2029-02-23 |
| Primary endpoint | Parts 1 and 2: Number of Participants With Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07166601 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:59.169Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07166601
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.